Publications by authors named "Gary Elliott"

Claim this Profile
F
Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor.
Umar Hayat, Gary T Elliott, Anthony J Olszanski, Dario C Altieri

Cancer Biol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 26-Week Toxicity Assessment of AIR001 (Sodium Nitrite) by Inhalation Exposure in Rats and by Intravenous Administration in Dogs.
Jeffrey Tepper, Ricardo Ochoa, Peter Rix, Gary Elliott, Niel Hoglen

Int J Toxicol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes.
Donglin Guo, Que Liu, Tengxian Liu, Gary Elliott, Mireille Gingras

J Cardiovasc Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A software framework enabling analysis of plate-based flow cytometry data for high-throughput screening.
Rick A Stanton, Sonia Escobar, Gary S Elliott

Assay Drug Dev Technol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical characterization of AMG 102: a neutralizing, fully human monoclonal antibody to human and nonhuman primate hepatocyte growth factor.
Teresa L Burgess, Jan Sun, Susanne Meyer, Trace S Tsuruda, Jilin Sun, Gary Elliott

Mol Cancer Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving pictures: imaging flow cytometry for drug development.
Gary S Elliott

Comb Chem High Throughput Screen· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys.
Hai Yan, Wei Gu, Jie Yang, Vivian Bi, Yuqing Shen, Gary S Elliott

J Pharmacol Exp Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents.
Lorenzo M Leoni, Brandi Bailey, Jack Reifert, Heather H Bendall, Robert W Zeller, Gary Elliott

Clin Cancer Res· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma.
Suzanne Lentzsch, Gary Elliott, G David Roodman

Arch Pharm (Weinheim)· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.
Elin Lindhagen, Sara Nissle, Lorenzo Leoni, Gary Elliott, Qi Chao

Cancer Chemother Pharmacol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro.
Elin Lindhagen, Linda Rickardson, Gary Elliott, Lorenzo Leoni, Peter Nygren

Invest New Drugs· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.
Rentian Feng, Gülsüm Anderson, Guozhi Xiao, Gary Elliott, Lorenzo Leoni

Blood· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
Paola Neri, Hiroshi Yasui, Teru Hideshima, Pierfrancesco Tassone, Noopur Raje, Gary T Elliott

Br J Haematol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.
Damian M Kraus, Gary S Elliott, Hilary Chute, Thomas Horan, Karl H Pfenninger

J Immunol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
Teresa Burgess, Angela Coxon, Susanne Meyer, Jan Sun, Karen Rex, Gary Elliott

Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circadian pharmacology of L-alanosine (SDX-102) in mice.
Xiao-Mei Li, Sarath Kanekal, Delphine Crépin, Catherine Guettier, Jennifer Carrière, Gary Elliott

Mol Cancer Ther· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.
Hiroshi Yasui, Teru Hideshima, Makoto Hamasaki, Aldo M Roccaro, Norihiko Shiraishi, Gary Elliott

Blood· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of derivatized l-alanosine in plasma by liquid chromatography-tandem mass spectrometry.
Alex Gantverg, Gary Elliott, Jean Pineault, Roger Demers

J Chromatogr B Analyt Technol Biomed Life Sci· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
Josette Carnahan, Paul Wang, Richard Kendall, Ching Chen, Sylvia Hu, Gary Elliott

Clin Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1).
Seiji Kondo, Ying Lu, Michael Debbas, Athena W Lin, Ildiko Sarosi, Gary Elliott

Proc Natl Acad Sci U S A· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production.
Mee Rhan Kim, Raffi Manoukian, Richard Yeh, Scott M Silbiger, Dimitry M Danilenko, Gary Elliott

Blood· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyglutamine repeat length-dependent proteolysis of huntingtin.
Banghua Sun, Wei Fan, Aldona Balciunas, Jillian K Cooper, Gal Bitan, Gary Elliott

Neurobiol Dis· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant.
Paul Baldrick, Derek Richardson, Gary Elliott, Alan W Wheeler

Regul Toxicol Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis